Document is current
Any future updates will be listed below
-
Authors
Aivazidis, Alexander
Memi, Fani https://orcid.org/0000-0002-3685-1988
Kleshchevnikov, Vitalii https://orcid.org/0000-0001-9110-7441
Er, Sezgin https://orcid.org/0000-0001-7266-9844
Clarke, Brian https://orcid.org/0000-0002-6695-286X
Stegle, Oliver https://orcid.org/0000-0002-8818-7193
Bayraktar, Omer Ali https://orcid.org/0000-0001-6055-277X
-
Funding
Funding for this research was provided by:
Wellcome Trust (220540/Z/20/A, 206194)
European Commission (ERC project DECODE, 810296)
- License Information
-
More Information
Article History
Received: 2 August 2023
Accepted: 23 January 2025
First Online: 3 March 2025
Competing interests
: O.S. is a paid advisor of insitro. B.C. holds equity in Tachyon Therapeutics. The other authors declare no competing interests.
